The BE (2)-M17 cell line has a better dopaminergic phenotype than the traditionally used for Parkinson´s research SH-SY5Y, which is mostly serotonergic
SH-SY5Y is a cell line derived from human neuroblastoma. It is one of the most widely used in vitro models to study Parkinson’s disease. Surprisingly, it has been found that it does not develop a dopaminergic phenotype after differentiation, questioning its usefulness as a Parkinson’s model. There a...
Main Authors: | Angel Carvajal-Oliveros, Maritere Uriostegui-Arcos, Mario Zurita, Erika I. Melchy-Perez, Verónica Narváez-Padilla, Enrique Reynaud |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | IBRO Neuroscience Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242122000963 |
Similar Items
-
Retinoic Acid-Differentiated Neuroblastoma SH-SY5Y Is an Accessible In Vitro Model to Study Native Human Acid-Sensing Ion Channels 1a (ASIC1a)
by: Aleksandr P. Kalinovskii, et al.
Published: (2022-01-01) -
Temporal Quantitative Proteomic and Phosphoproteomic Profiling of SH-SY5Y and IMR-32 Neuroblastoma Cells during All-<i>Trans</i>-Retinoic Acid-Induced Neuronal Differentiation
by: Thomas C. N. Leung, et al.
Published: (2024-01-01) -
Firing properties of genetically identified dorsal raphe serotonergic neurons in brain slices.
by: Boris Mlinar, et al.
Published: (2016-08-01) -
Bioinformatics Study of the Effect of Brain-derived Neurogenic Factor (BDNF) on Gene Expression in SH-SY5Y Cell Line
by: Korosh Bamdad, et al.
Published: (2019-06-01) -
A transcription factor collective defines the HSN serotonergic neuron regulatory landscape
by: Carla Lloret-Fernández, et al.
Published: (2018-03-01)